Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $14.9 billion.

  • Eastman Chemical's Liabilities and Shareholders Equity fell 232.7% to $14.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $60.0 billion, marking a year-over-year increase of 10.34%. This contributed to the annual value of $14.9 billion for FY2025, which is 232.7% down from last year.
  • Per Eastman Chemical's latest filing, its Liabilities and Shareholders Equity stood at $14.9 billion for Q4 2025, which was down 232.7% from $15.0 billion recorded in Q3 2025.
  • Eastman Chemical's 5-year Liabilities and Shareholders Equity high stood at $16.3 billion for Q3 2021, and its period low was $14.6 billion during Q3 2023.
  • Its 5-year average for Liabilities and Shareholders Equity is $15.2 billion, with a median of $15.0 billion in 2023.
  • As far as peak fluctuations go, Eastman Chemical's Liabilities and Shareholders Equity tumbled by 783.57% in 2022, and later skyrocketed by 396.36% in 2024.
  • Quarter analysis of 5 years shows Eastman Chemical's Liabilities and Shareholders Equity stood at $15.5 billion in 2021, then fell by 5.49% to $14.7 billion in 2022, then dropped by 0.23% to $14.6 billion in 2023, then increased by 3.96% to $15.2 billion in 2024, then fell by 2.33% to $14.9 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $14.9 billion for Q4 2025, versus $15.0 billion for Q3 2025 and $15.2 billion for Q2 2025.